Clinical trial
Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases…
NCT00168155 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00168155 |
|---|---|
| Title | Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma |
| Official title | Phase 2 Study of Neoadjuvant 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma |
| Lead sponsor | Alberta Health services, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Adenocarcinoma, Liver Metastases |
| Intervention type | Drug |
| Interventions | perioperative chemotherapy |
| Enrollment | 70 |
| Start date | Jan 1, 2002 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: